References
- Deb P, Sharma S, Hassan KM. 2010. Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiol Official J Int Soc Pathophysiol. 17:197–218.10.1016/j.pathophys.2009.12.001
- Diao X, Pang X, Xie C, Guo Z, Zhong D, Chen X. 2014. Bioactivation of 3-n-butylphthalide via sulfation of its major metabolite 3-hydroxy-NBP: mediated mainly by sulfotransferase 1A1. Drug Metab Dispos Biol Fate Chem. 42:774–781.10.1124/dmd.113.056218
- Feng X, Peng Y, Liu M, Cui L. 2012. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis. Neuropharmacology. 62:1004–1010.10.1016/j.neuropharm.2011.10.009
- Jasamai M, Jalil J, Jantan I. 2015. Molecular docking study on platelet-activating factor antagonistic activity of bioactive compounds isolated from Guttiferae and Ardisia species. Nat Prod Res. 29:1055–1058.10.1080/14786419.2014.971317
- Li Y, Wang X, Fu R, Yu W, Wang X, Lai Y, Peng S, Zhang Y. 2011. Synthesis and evaluation of nitric oxide-releasing derivatives of 3-n-butylphthalide as anti-platelet agents. Bioorg Med Chem Lett. 21:4210–4214.
- Peng B, Cui LY. 2013. Treatment for acute ischemic stroke: new evidence from China. Chin Med J. 126:3403–3404.
- Son DJ, Park YO, Yu C, Lee SE, Park YH. 2014. Bioassay-guided isolation and identification of anti-platelet-active compounds from the root of Ashitaba (Angelica keiskei Koidz.). Nat Prod Res. 28:2312–2316.10.1080/14786419.2014.931389
- Tran PH, Tran TT, Lee BJ. 2013. Enhanced solubility and modified release of poorly water-soluble drugs via self-assembled gelatin-oleic acid nanoparticles. Int J Pharm. 455:235–240.10.1016/j.ijpharm.2013.07.025
- Wu J, Ling J, Wang X, Li T, Liu J, Lai Y, Ji H, Peng S, Tian J, Zhang Y. 2012. Discovery of a potential anti-ischemic stroke agent: 3-pentylbenzo[c]thiophen-1(3H)-one. J Med Chem. 55:7173–7181.10.1021/jm300681r
- Yang H, Hu GY, Chen J, Wang Y, Wang ZH. 2007. Synthesis, resolution, and antiplatelet activity of 3-substituted 1(3H)-isobenzofuranone. Bioorg Med Chem Lett. 17:5120–5123.